(Q41103084)

26 September 2017

1 reference

title

Evolution and plasticity of CTL responses against HIV. (English)

1 reference

26 September 2017

Autran B

1

1 reference

PubMed ID

8794018

26 September 2017

Hadida F

series ordinal

2

1 reference

PubMed ID

8794018

26 September 2017

Haas G

series ordinal

3

1 reference

26 September 2017

1 August 1996

1 reference

Current Opinion in Immunology

26 September 2017

1 reference

26 September 2017

8

1 reference

26 September 2017

546-553

1 reference

26 September 2017

4

1 reference

Can the immune response control HIV infection?

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Intratumoral activation of CD8-positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Effects of HIV-1 Tat on expression of HLA class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

T cell receptor antagonists and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Population dynamics of immune responses to persistent viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Predominant involvement of CD8+CD28- lymphocytes in human immunodeficiency virus-specific cytotoxic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Reduction of HIV concentration during acute infection: independence from a specific immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2896%2980045-8

7 January 2021

10.1016/S0952-7915(96)80045-8

Identifiers

DOI

1 reference

26 September 2017

1 reference

PubMed ID

8794018